Search
for
Sort by
Research 151–180 of 1000+
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Eosinophilic Fasciitis Associated With Tryptophan Ingestion
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- The use of Minoxidil in the Treatment of Severe Essential Hypertension: A Report on 100 Patients
- Dermatological aspects of the S2k guidelines on Down syndrome in childhood and adolescence
- The risk of dermatological toxicities of combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma patients: a systematic review and meta-analysis
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Acquired Localized Hypertrichosis Following Pressure Garment and/or Silicone Therapy in Burn Patients
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- COVID-19 pandemic and teledermatology in low-income regions
- P029 A case of atypical bullous pemphigoid
- Pediatric Inpatients Requesting Dermatology Consultation in a Tertiary Care Hospital: Retrospective Analysis of 614 Patients
- Daclizumab
- Low Serum Biotinidase Activity in Children with Valproic Acid Monotherapy
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Co-existence of Systemic Lupus Erythematosus and Celiac Disease: A Case Report
- 9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma
- Gefitinib: an adverse effects profile
- A STUDY OF MUCOCUTANEOUS MANIFESTATIONS IN AUTOIMMUNE CONNECTIVE TISSUE DISORDERS AT TERTIARY CARE CENTRE
- Chemotherapy and Cutaneous Drug Reactions
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Diseases of the skin. Drug ill effects on the skin.
- Caution in the time of rashes and COVID-19
- Skin amidst COVID ‐19 pandemic
- Extensive scarring alopecia and widespread rash
- Case 1: Intractable Rash in a 7-month-old Boy
- Skin Manifestations of Targeted Antineoplastic Therapy
- H12 Royal rashes: a potted dermatology history in the British monarchy
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases